共 22 条
[2]
Bazzino O, 1998, NEW ENGL J MED, V338, P1488
[3]
BENYEHUDA O, 2004, MOL BASIS CARDIOVASC
[4]
Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions - The EVEREST trial
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
2006, 47 (03)
:522-528
[5]
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-Segment elevation myocardial infarction - Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
2002, 40 (07)
:1366-1374
[7]
Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
2004, 44 (09)
:1792-1800
[9]
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel - Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
2004, 43 (02)
:162-168